Korakianitis Odysseus, Daskalou Telemachos, Alevizos Leonidas, Stamou Konstantinos, Mavroudis Christos, Iatrou Christos, Vogiatzaki Theodosia, Eleftheriadis Savvas, Tentes Antonios Apostolos
a Department of Anaesthesiology , Didimoticho General Hospital , Didimoticho , Greece .
b Department of Haematology , Sismanogleio Hospital , Athens , Greece .
Int J Hyperthermia. 2015;31(8):857-62. doi: 10.3109/02656736.2015.1075606. Epub 2015 Oct 8.
The purpose of this study is to evaluate the fluctuations of coagulation parameters during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) and confirm beyond doubt that epidural anaesthesia is safe with this type of operations.
This is a prospective clinical study of consecutive patients who had cytoreductive surgery and HIPEC. An epidural catheter was inserted into all patients. Peripheral venous blood samples in specific time points of the procedure were tested for complete blood count, prothrombin time (PT), activated partial thromboplastin time (aPTT), international normalised ratio (INR), fibrinogen, D-dimer, and expression of the GpIIb/IIIa platelet receptor.
A total of 51 consecutive patients were included in this study. The initial mean (SD) platelet count decreased significantly to a mean of 250.6 (105.4) 10(9)/L (p < 0.001). Fibrinogen levels decreased to 295.9 (127.4) mg/dL (p = 0.009). D-dimer levels increased to 5.3 (3.1) mg/dL (p < 0.001). APTT increased from 30.8 (5.8) s to 35.1 (4.6). The mean INR increased significantly to 1.5 (0.5) (p < 0.001). The total number of GpIIb/IIIa platelet receptors showed no significant variation throughout the measurements and was 72603.2 before HIPEC, 80772.4 during, and 77432.1 after. All the parameters examined, despite significant fluctuations remained in levels that would permit perioperative epidural analgesia. No related complications were recorded.
Our results support the belief that epidural analgesia is a safe option in cytoreductive surgery and HIPEC despite certain intraoperative fluctuations in coagulation parameters. It is of major importance to regulate any abnormalities observed during surgery. There are no available data regarding the occurrence of coagulopathy in the post-operative period.
本研究旨在评估肿瘤细胞减灭术及热灌注化疗(HIPEC)期间凝血参数的波动情况,并确凿证实硬膜外麻醉用于此类手术是安全的。
这是一项针对接受肿瘤细胞减灭术及HIPEC的连续患者的前瞻性临床研究。所有患者均置入硬膜外导管。在手术的特定时间点采集外周静脉血样本,检测全血细胞计数、凝血酶原时间(PT)、活化部分凝血活酶时间(aPTT)、国际标准化比值(INR)、纤维蛋白原、D-二聚体以及血小板糖蛋白IIb/IIIa受体的表达。
本研究共纳入51例连续患者。初始平均(标准差)血小板计数显著降至平均250.6(105.4)×10⁹/L(p<0.001)。纤维蛋白原水平降至295.9(127.4)mg/dL(p = 0.009)。D-二聚体水平升至5.3(3.1)mg/dL(p<0.001)。aPTT从30.8(5.8)秒增至35.1(4.6)秒。平均INR显著升至1.5(0.5)(p<0.001)。血小板糖蛋白IIb/IIIa受体总数在整个测量过程中无显著变化,热灌注化疗前为72603.2,术中为80772.4,术后为77432.1。所有检测参数尽管有显著波动,但仍处于允许围手术期硬膜外镇痛的水平。未记录到相关并发症。
我们的结果支持以下观点,即尽管术中凝血参数有一定波动,但硬膜外镇痛对于肿瘤细胞减灭术及热灌注化疗而言是一种安全的选择。对手术期间观察到的任何异常情况进行调控至关重要。关于术后凝血功能障碍的发生尚无可用数据。